Revolad
(Eltrombopag)
(50 mg)
(fourteen)
(Tablets)
Revolad (Eltrombopag) 50 mg 14 tab. or 25 mg 28 tab NOVARTIS, Switzerland
Article:
testimony
- Treatment of adult patients with chronic idiopathic thrombocytopenic purpura (ITP) who have undergone splenectomy and are not responding to treatment with other drugs (eg, corticosteroids, immunoglobulins). As a second-line drug for the treatment of adult patients who have not undergone splenectomy due to contraindications to surgery.
- 215 50/14sham300/20pash/ules
- Treatment of thrombocytopenia in adult patients with chronic viral hepatitis C (HCV) to enable and optimize antiviral therapy, including interferon.
-
Commercial name:Revolad
-
Сhemical name:Eltrombopag
-
Dosage:50 mg
-
Quantity:fourteen
-
Release form:Tablets
No reviews yet